• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    Aegerion Pharmaceuticals, Inc. (AEGR)

    -NasdaqGS
    25.22 Down 0.83(3.19%) Apr 17, 4:00PM EDT
    |After Hours : 25.22 Down 0.00 (0.01%) Apr 17, 4:22PM EDT
    Add to Portfolio
    Prev Close:26.05
    Open:25.84
    Bid:25.21 x 300
    Ask:26.96 x 2000
    1y Target Est:26.83
    Beta:0.16
    Earnings Date:May 4 - May 8 (Est.)
    Day's Range:25.08 - 25.86
    52wk Range:19.10 - 47.13
    Volume:436,308
    Avg Vol (3m):585,250
    Market Cap:719.75M
    P/E (ttm):N/A
    EPS (ttm):-1.35
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AEGR

    Comparison

    Symbol% ChgMkt Cap
    AEGRDown 3.19%719.75M
    AZNDown 0.99%90.09B
    MRKDown 1.66%161.44B
    PFEDown 0.43%214.76B

    Key Statistics

    Forward P/E (1 yr):420.33
    P/S (ttm):4.69
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.51
    Quarterly EPS Est (Mar-15) :-0.26
    Mean Recommendation*:2.9
    PEG Ratio (5 yr expected):-3.38

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback